| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 785.555 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 695.639 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 609.563 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 822.467 | 95 |
| GSM780720 | Untreated after 4 days (C2_2) | 744.043 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 648.44 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 562.124 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 772.996 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 732.027 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 571.903 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 810.536 | 95 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 807.259 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 783.583 | 94 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 660.64 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 791.077 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 818.813 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 691.775 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 748.728 | 94 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 757.684 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 770.494 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 646.978 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 732.859 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 743.467 | 94 |